| scholarly article | Q13442814 |
| P2093 | author name string | Masataka Sata | |
| Koichi Node | |||
| Hiroshi Komoda | |||
| Teruo Inoue | |||
| Toshihiko Uchida | |||
| Daiju Fukuda | |||
| Yutaka Hikichi | |||
| Minoru Shimizu | |||
| Ryoichi Sohma | |||
| P2860 | cites work | Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand | Q24644662 |
| Neutrophil gelatinase B and chemokines in leukocytosis and stem cell mobilization | Q28216983 | ||
| Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? | Q28240919 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization | Q30876047 | ||
| Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation | Q34960327 | ||
| Inflammation and restenosis in the stent era. | Q34993928 | ||
| A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits | Q36286707 | ||
| Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18) | Q36368770 | ||
| Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty | Q37175241 | ||
| Expression of granulocyte colony-stimulating factor is induced in injured rat carotid arteries and mediates vascular smooth muscle cell migration | Q38336264 | ||
| Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial | Q38408849 | ||
| Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl | Q40525372 | ||
| Smooth muscle progenitor cells in human blood | Q44123747 | ||
| Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. | Q45121029 | ||
| Potent inhibitory effect of sirolimus on circulating vascular progenitor cells | Q45264961 | ||
| Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry | Q46489660 | ||
| Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis | Q48004482 | ||
| Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease. | Q51341585 | ||
| Ligation of selectin L and integrin CD11b/CD18 (Mac-1) induces release of gelatinase B (MMP-9) from human neutrophils. | Q64906412 | ||
| Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia | Q68182874 | ||
| Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty | Q71724509 | ||
| Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris | Q73179074 | ||
| Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling | Q74147587 | ||
| Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis | Q77859042 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | stem cell proliferation | Q14865102 |
| CD34 molecule | Q4035578 | ||
| bone marrow | Q546523 | ||
| P304 | page(s) | 553-61 | |
| P577 | publication date | 2007-02-06 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis | |
| P478 | volume | 115 |
| Q84963515 | Activation of matrix metalloproteinase-9 is associated with mobilization of bone marrow-derived cells after coronary stent implantation |
| Q85190611 | Association Between Circulating Monocyte Subsets and In-Stent Restenosis After Coronary Stent Implantation in Patients With ST-Elevation Myocardial Infarction |
| Q33805068 | Association between high-density lipoprotein-cholesterol and hypertension in relation to circulating CD34-positive cell levels. |
| Q35392119 | Association between microalbuminuria predicting in-stent restenosis after myocardial infarction and cellular senescence of endothelial progenitor cells |
| Q36242530 | Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome. |
| Q34724214 | Bioactive stent surface coating that promotes endothelialization while preventing platelet adhesion |
| Q42232032 | Biocompatibility of Coronary Stents |
| Q34186552 | CD34 affinity pheresis attenuates a surge among circulating progenitor cells following vascular injury |
| Q37739010 | Cell-based methods for ex vivo evaluation of human endothelial biology. |
| Q42844265 | Cellular and Molecular Changes Associated With Inhibitory Effect of Pioglitazone on Neointimal Growth in Patients With Type 2 Diabetes After Zotarolimus-Eluting Stent Implantation |
| Q37293820 | Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence |
| Q33649275 | Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. |
| Q39781636 | Differentiation profile of peripheral blood-derived vascular progenitor cell predicts intimal hyperplasia after coronary stenting |
| Q37144221 | Drug-eluting stents - what should be improved? |
| Q37809388 | Drug-eluting stents for coronary artery disease: A review |
| Q34658637 | E-selectin mediated adhesion and migration of endothelial colony forming cells is enhanced by SDF-1α/CXCR4. |
| Q47126850 | Endothelial Progenitor Cell Biology and Vascular Recovery Following Transradial Cardiac Catheterization |
| Q24202607 | Endothelial progenitor cell capture stents versus drug-eluting stents for angina or acute coronary syndrome |
| Q42494769 | Endothelial progenitor cells mobilisation after percutaneous coronary intervention: a pilot study |
| Q21198698 | Endothelial progenitor cells: what use for the cardiologist? |
| Q24568374 | Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression |
| Q46832582 | Local insulin application on the carotid artery inhibits neointima formation |
| Q53230722 | Long-Term Effects of Novel Combination Coating Anti-CD34 Antibody Applied on Sirolimus-Eluting Stents. |
| Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
| Q34304812 | Microelectromechanical systems and nanotechnology: a platform for the next stent technological era. |
| Q54496757 | Mobilization of CD34+ KDR+ endothelial progenitor cells predicts target lesion revascularization. |
| Q52647550 | Mobilization of progenitor cells and assessment of vessel healing after second generation drug-eluting stenting by optical coherence tomography. |
| Q37041823 | Neo-intimal hyperplasia, diabetes and endovascular injury |
| Q42849806 | One-year clinical outcome after provisional T-stenting for bifurcation lesions with the endothelial progenitor cell capturing stent compared with the bare-metal stent |
| Q28654918 | Percutaneous coronary intervention causes a rapid but transient mobilisation of CD34(+)CD45(-) cells |
| Q28728533 | Pericardial patch angioplasty heals via an Ephrin-B2 and CD34 positive cell mediated mechanism |
| Q37269376 | Pharmacological approaches to improve endothelial repair mechanisms |
| Q50518644 | Phenotype and differentiation of bone marrow-derived smooth muscle progenitor cells. |
| Q51806831 | Polymorphonuclear blood leukocytes and restenosis after intracoronary implantation of drug-eluting stents. |
| Q33808599 | Pre-procedural atorvastatin mobilizes endothelial progenitor cells: clues to the salutary effects of statins on healing of stented human arteries |
| Q37053167 | Progenitor cells and vascular disease |
| Q33776274 | Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells |
| Q37944416 | Restenosis after PCI. Part 2: prevention and therapy |
| Q92226447 | Short-term Safety and Mid-term Efficacy of Prasugrel Versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention |
| Q36393058 | The A2b adenosine receptor protects against vascular injury |
| Q51014960 | The late-phase inflammatory response after drug-eluting stent implantation. |
| Q44941164 | Three-year clinical follow-up of an unselected patient population treated with the genous endothelial progenitor cell capturing stent |
| Q37570669 | Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases |
| Q50462523 | Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model. |
| Q50300607 | Vascular Calcification: Is it rather a Stem/Progenitor Cells Driven Phenomenon? |
| Q35079541 | Vascular endothelial growth factor-bound stents: application of in situ capture technology of circulating endothelial progenitor cells in porcine coronary model |
| Q35927338 | Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis |
| Q37832151 | Vascular smooth muscle cell motility: From migration to invasion |
| Q83739181 | [Perspectives of regenerative mechanisms in cardiovascular disease spotlighting endothelial progenitor cells] |
Search more.